A growing shortage of common cancer treatments is forcing doctors to switch medications and delaying some care, prominent U.S. cancer centers say. The National Comprehensive Cancer Network said Wednesday that nearly all the centers it surveyed late last month were dealing with shortages of carboplatin and cisplatin, a pair of drugs used to treat a range of ...

The arguments that hospitals’ trade groups have used for years — mainly, that they need more money from the government — are beginning to fall flat, indicating one of Washington’s most powerful lobbying juggernauts may be losing some goodwill. While groups like the American Hospital Association, which represents about 5,000 hospitals and which spent $27 ...

Policy analysts, Democrats, and Republicans dissatisfied with the deal agree: Federal health programs have dodged a budgetary bullet in the Washington showdown over raising the nation’s debt ceiling.

Employers are bracing for 2024, fearing they’ll face inflation and soaring healthcare costs while still trying to recruit and retain workers in a tight labor market, a new survey shows.

A federal appeals court will hear arguments Tuesday about whether to continue a pause of a Texas district court’s ruling that struck down an ObamaCare provision requiring insurers to cover preventive services for free.

The U.S. Food and Drug Administration has authorized the temporary importation of an unapproved chemotherapy drug from China in effort to ease an acute shortage of cancer drugs in the United States, according to an update posted to the agency’s website Friday.